Hydroxychloroquine (HCQ): real treatment or false hope?
作者信息
El Bakkouri Karim
机构信息
SciMed Services & Solutions, BLSI, Clos Chapelle-aux-Champs, 30 B-1200 Brussels, Belgium.
出版信息
Int J Antimicrob Agents. 2021 Jan;57(1):106170. doi: 10.1016/j.ijantimicag.2020.106170.
Abstract
摘要
相似文献
1
Hydroxychloroquine (HCQ): real treatment or false hope?羟氯喹（HCQ）：是切实有效的治疗方法还是虚幻的希望？
Int J Antimicrob Agents. 2021 Jan;57(1):106170. doi: 10.1016/j.ijantimicag.2020.106170.
2
Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.羟氯喹和阿奇霉素对新型冠状病毒肺炎患者严重急性呼吸综合征冠状病毒2清除率的影响：一项荟萃分析
Int J Antimicrob Agents. 2021 Jan;57(1):106240. doi: 10.1016/j.ijantimicag.2020.106240.
3
Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19.用于2019冠状病毒病诊断的严重急性呼吸综合征冠状病毒2聚合酶链反应结果解读
Int J Antimicrob Agents. 2021 Jan;57(1):106238. doi: 10.1016/j.ijantimicag.2020.106238.
4
Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes.羟氯喹和阿奇霉素治疗COVID-19的效果：一项开放标签非随机临床试验的结果，意向性分析及临床结局的更新
Int J Antimicrob Agents. 2021 Jan;57(1):106239. doi: 10.1016/j.ijantimicag.2020.106239.
5
An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia.针对从印度尼西亚泗水住院患者中分离出的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒，开展抗病毒药物、抗生素和/或羟氯喹的双药组合体外研究。
PLoS One. 2021 Jun 18;16(6):e0252302. doi: 10.1371/journal.pone.0252302. eCollection 2021.
6
Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response.羟氯喹啉联合或不联合阿奇霉素对COVID-19患者死亡率的影响：作者回应
Clin Microbiol Infect. 2021 Jan;27(1):138-140. doi: 10.1016/j.cmi.2020.10.002. Epub 2020 Oct 17.
7
Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load.羟氯喹和阿奇霉素对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒载量的影响尚不确定。
Int J Antimicrob Agents. 2021 Jan;57(1):106169. doi: 10.1016/j.ijantimicag.2020.106169.
8
Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann.羟氯喹和阿奇霉素对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒清除的影响：对埃尔韦·塞利格曼的回应
Int J Antimicrob Agents. 2021 Mar;57(3):106306. doi: 10.1016/j.ijantimicag.2021.106306. Epub 2021 Feb 14.
9
Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19.羟氯喹啉和阿奇霉素治疗新型冠状病毒肺炎的临床疗效及安全性概况
Int J Antimicrob Agents. 2021 Jan;57(1):106242. doi: 10.1016/j.ijantimicag.2020.106242.
10
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited.羟氯喹和阿奇霉素用于治疗新型冠状病毒肺炎：重新审视一项开放标签非随机临床试验的结果
Int J Antimicrob Agents. 2021 Jan;57(1):106243. doi: 10.1016/j.ijantimicag.2020.106243.
引用本文的文献
1
Science's Response to CoVID-19.科学应对新冠病毒。
ChemMedChem. 2021 Aug 5;16(15):2288-2314. doi: 10.1002/cmdc.202100079. Epub 2021 Jun 22.
2
Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19.用于2019冠状病毒病诊断的严重急性呼吸综合征冠状病毒2聚合酶链反应结果解读
Int J Antimicrob Agents. 2021 Jan;57(1):106238. doi: 10.1016/j.ijantimicag.2020.106238.
本文引用的文献
1
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
Zotero 插件